Premier Path Wealth Partners, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Premier Path Wealth Partners, LLC
- $718 Billion
- Q2 2025
A detailed history of Premier Path Wealth Partners, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 20,265 shares of AMLX stock, worth $309,851. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,265
Previous 20,265
-0.0%
Holding current value
$309,851
Previous $71.7 Million
81.07%
% of portfolio
0.02%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AMLX
# of Institutions
150Shares Held
76.4MCall Options Held
212KPut Options Held
40.6K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.8MShares$135 Million0.1% of portfolio
-
Perceptive Advisors LLC New York, NY7.9MShares$121 Million2.22% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.94MShares$90.9 Million7.77% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.54MShares$69.4 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$68.8 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $895M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...